How would you rate it?
According to the United States Food and Drug Administration (FDA) FAERS database , zempic and other popular GLP-1 weight loss drugs, including Wegovy and Mounjaro, have been associated with a total of 162 deaths in the United States over the past six years
Methodology and Sources This analysis is based on publicly available sources as of December 26, 2025: FDA communications: Compounding safety alerts, prescribing information, and regulatory guidance Novo Nordisk announcements: Wegovy pill approval, OASIS 4 trial results, pricing disclosures Independent reporting and primary sources: ABC News coverage and Novo Nordisk's announcement on December 22, 2025 FDA oral Wegovy approval MEDVi terms and disclosures: Platform structure, pricing, and regulatory disclaimers Key Sources Cited: ABC News: "FDA approves Wegovy pill for weight loss" (December 22, 2025) Novo Nordisk: Official press release on FDA approval and OASIS 4 trial data (December 22, 2025) FDA Safety Communications: 20242025 alerts on compounded semaglutide dosing errors All regulatory references are based on FDA publications and third-party reporting available at the time of publication
This research compound enables the study of dual-mechanism growth hormone modulation, examining how Tesamorelins GHRH-mimicking properties interact with Ipamorelins selective ghrelin-like functions in experimental models
